Logo image of ZEV

LIGHTNING EMOTORS INC (ZEV) Stock Fundamental Analysis

USA - NYSE:ZEV - US53228T2006 - Common Stock

1.63 USD
-0.09 (-5.23%)
Last: 9/18/2023, 8:04:00 PM
Fundamental Rating

1

Taking everything into account, ZEV scores 1 out of 10 in our fundamental rating. ZEV was compared to 129 industry peers in the Machinery industry. ZEV has a bad profitability rating. Also its financial health evaluation is rather negative. ZEV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZEV has reported negative net income.
In the past year ZEV has reported a negative cash flow from operations.
ZEV Yearly Net Income VS EBIT VS OCF VS FCFZEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M -60M -80M -100M

1.2 Ratios

The profitability ratios for ZEV are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEV Yearly ROA, ROE, ROICZEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZEV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEV Yearly Profit, Operating, Gross MarginsZEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -100 -200 -300 -400

More info and screens

1

2. Health

2.1 Basic Checks

ZEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZEV has more shares outstanding
Compared to 1 year ago, ZEV has a worse debt to assets ratio.
ZEV Yearly Shares OutstandingZEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M
ZEV Yearly Total Debt VS Total AssetsZEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

ZEV has an Altman-Z score of -4.93. This is a bad value and indicates that ZEV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ZEV (-4.93) is worse than 94.57% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ZEV is not too dependend on debt financing.
ZEV has a better Debt to Equity ratio (0.16) than 76.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -4.93
ROIC/WACCN/A
WACC9.73%
ZEV Yearly LT Debt VS Equity VS FCFZEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.16 indicates that ZEV should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, ZEV is doing worse than 89.15% of the companies in the same industry.
ZEV has a Quick Ratio of 1.16. This is a bad value and indicates that ZEV is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEV's Quick ratio of 0.38 is on the low side compared to the rest of the industry. ZEV is outperformed by 96.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.38
ZEV Yearly Current Assets VS Current LiabilitesZEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ZEV have decreased strongly by -5228.57% in the last year.
Looking at the last year, ZEV shows a very strong growth in Revenue. The Revenue has grown by 27.11%.
EPS 1Y (TTM)-5228.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1157.14%
Revenue 1Y (TTM)27.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%123.87%

3.2 Future

ZEV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.68% yearly.
ZEV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 95.00% yearly.
EPS Next Y-476.84%
EPS Next 2Y-67.85%
EPS Next 3Y1.68%
EPS Next 5YN/A
Revenue Next Year27.94%
Revenue Next 2Y77.77%
Revenue Next 3Y95%
Revenue Next 5YN/A

3.3 Evolution

ZEV Yearly Revenue VS EstimatesZEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 50M 100M 150M 200M
ZEV Yearly EPS VS EstimatesZEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZEV. In the last year negative earnings were reported.
Also next year ZEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEV Price Earnings VS Forward Price EarningsZEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEV Per share dataZEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.85%
EPS Next 3Y1.68%

More info and screens

0

5. Dividend

5.1 Amount

ZEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIGHTNING EMOTORS INC

NYSE:ZEV (9/18/2023, 8:04:00 PM)

1.63

-0.09 (-5.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)11-06 2023-11-06/bmo
Inst Owners0.19%
Inst Owner Change0%
Ins Owners521.24%
Ins Owner Change0%
Market Cap10.02M
Analysts72.5
Price Target35.32 (2066.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.88%
Min EPS beat(2)-21.1%
Max EPS beat(2)-16.66%
EPS beat(4)2
Avg EPS beat(4)28.77%
Min EPS beat(4)-21.1%
Max EPS beat(4)93.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-38.88%
Min Revenue beat(2)-78.63%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-27.72%
Min Revenue beat(4)-78.63%
Max Revenue beat(4)24.89%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.1%
PT rev (3m)-0.79%
EPS NQ rev (1m)14.98%
EPS NQ rev (3m)-22.25%
EPS NY rev (1m)-12.14%
EPS NY rev (3m)-1822.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.21%
Revenue NY rev (1m)-3.79%
Revenue NY rev (3m)-12.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-11.19
EYN/A
EPS(NY)-6.73
Fwd EYN/A
FCF(TTM)-18.81
FCFYN/A
OCF(TTM)-17.75
OCFYN/A
SpS4.02
BVpS3.73
TBVpS3.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 288.21%
Cap/Sales 26.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.38
Altman-Z -4.93
F-Score2
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5228.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1157.14%
EPS Next Y-476.84%
EPS Next 2Y-67.85%
EPS Next 3Y1.68%
EPS Next 5YN/A
Revenue 1Y (TTM)27.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%123.87%
Revenue Next Year27.94%
Revenue Next 2Y77.77%
Revenue Next 3Y95%
Revenue Next 5YN/A
EBIT growth 1Y-42.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.43%
EBIT Next 3Y24.44%
EBIT Next 5YN/A
FCF growth 1Y-230.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-225.24%
OCF growth 3YN/A
OCF growth 5YN/A